TrialScientific reports2019

An abluminal biodegradable polymer sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients undergoing coronary revascularization: 3-year clinical outcomes of a randomized non-inferiority trial.

Haijun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.